Takeda has raised eyebrows after announcing its intention to bid for UK pharma Shire, with analysts suggesting the Japanese pharma will have to overpay to clinch the deal.
Sanofi’s is to pay back money to the Philippines government for unused doses of its Dengue fever vaccine, after serious safety concerns halted its use.
